about
Prevention, diagnosis and treatment of osteoporosis following menopause induced due to oncological disease.Treatment of menopausal symptoms post-Women's Health Initiative: refinement of existing treatments and development of new therapies.Fulvestrant: pharmacologic profile versus existing endocrine agents for the treatment of breast cancer.Skeletal complications of breast cancer therapiesResponses of urinary N-telopeptide and renal calcium handling to PTH infusion after treatment with estrogen, raloxifene, and tamoxifen.Preventive effect of risedronate on bone loss and frailty fractures in elderly women treated with anastrozole for early breast cancer
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Selective estrogen-receptor modulators.
@ast
Selective estrogen-receptor modulators.
@en
type
label
Selective estrogen-receptor modulators.
@ast
Selective estrogen-receptor modulators.
@en
prefLabel
Selective estrogen-receptor modulators.
@ast
Selective estrogen-receptor modulators.
@en
P1476
Selective estrogen-receptor modulators.
@en
P2093
Felicia Cosman
P304
P356
10.1016/S0749-0690(02)00114-3
P577
2003-05-01T00:00:00Z